Medapp S.A.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2010-10-26
Share capital
25,013,245.40 PLN
Activity description

Medapp is a company that develops 3D imaging technology and artificial intelligence for the medical field, specifically through its product CarnaLife Holo, which has received FDA certification. The company participates in medical technology exhibitions and collaborates with leading hospitals, such as the Medical University of Warsaw, for advanced medical procedures like heart ablation.

Registered address
Aleja Juliusza Słowackiego 6/10, 30-037 Kraków, Poland
Website
Email
Phone
Social media

Financials

Revenue history (in k)

Filing timeliness

4 of 6 financial statements were filed late (the longest delay 194 days for 2020). All were audited by a statutory auditor.

  • 202522/10/2026
  • 202410/07/2025
  • 202309/08/2024
  • 202208/01/2024
  • 202111/07/2022
  • 202027/04/2022
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Stock quotes

PLN 0.17
-0.00 (-1.78%)
0.160.170.170.1710:0012:0014:0016:00
Open
PLN 0.17
High
PLN 0.17
Low
PLN 0.17
Volume
31.11K
Avg. vol.
16.02K
Market cap
PLN 41.52M
P/E ratio
–
EPS
-PLN 0.01
Shares outstanding
250.13M
52-week
PLN 0.17 – 0.18
Dividend yield
–
Dividend
–
Ex dividend date
–
Exchange
NewConnect

Quarterly results

PeriodRevenueEBITNet profit
Q3 2026USD 276.61kUSD -210.97kUSD -220.42k
Q2 2026USD 819.56kUSD 302.54kUSD 291.46k
Q1 2026USD 798.22kUSD 139.38kUSD 131.82k
Q4 2025USD 203.16kUSD 132.60kUSD -22.60k

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 45%
Voivodeship · Małopolskie26,359 / 46,049
Top 57%
Country · Poland288,190 / 496,512
Top 58%

Results vs industry

Revenue
This companyUSD 100.45kMedianUSD 56.72kAverageUSD 2.72m
Net profit
This companyUSD -856.10kMedianUSD -1.27kAverageUSD -93.01k
Operating costs
This companyUSD 458.31kMedianUSD 66.48kAverageUSD 2.68m
Assets
This companyUSD 9.10mMedianUSD 134.71kAverageUSD 3.04m

Offer

  • Medical imaging software
  • CT and MRI image visualization
  • Anatomical holograms
  • Surgical navigation system

Websites

Trademarks

The company holds 1 active trademark registered with the Polish Patent Office. 2 marks have expired or were not registered. The first mark was filed in 2015.

MarkNumberClassesStatusProtected until
carnalife Z.4678309, 35, 41, 44Protected Feb 17, 2027
medapp mobile medical aplications (word)Z.4395509, 35, 45Refused –
medapp mobile medical aplications Z.4395519, 35, 45Not registered –
MarkProtected until
carnalife Feb 17, 2027
medapp mobile medical aplications (word)–
medapp mobile medical aplications –

Authorized Representatives

David Odrakiewicz age 37 – President of the Management Board

Manner of representation

In the case of a multi-member management board, declarations of will on behalf of the company must be made by two members of the management board acting jointly, or by two commercial proxies. In the case of a one-person management board, the sole member of the management board is independently authorized to make declarations of will on behalf of the company.

Supervisory board

Błażej Wasielewski age 43 – Supervisory Board Member
Ewelina Rytter age 38 – Supervisory Board Member
Malwina Grobelna age 36 – Supervisory Board Member
Michał Knapik age 47 – Supervisory Board Member
Włodzimierz Maciej Kubiak age 63 – Supervisory Board Member

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2010-11-26.

Debt

3 active proceedings recorded in KRZ.

Registration dateProceeding typeStatus
Jan 27, 2026
Accelerated arrangement proceedings
In progress
Dec 29, 2025
Petition to open accelerated arrangement proceedings
Closed
Nov 19, 2025
Petition to declare entrepreneur bankruptcy
Closed

Public aid

22 public aid cases recorded, with a total value of $1,587,532.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
–
Aid for research and development projects: industrial research
–
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
–

European Funds

4 EU budget awards (FTS) recorded, totalling $1,441,013.

ProjectEU co-financing
We are health champions - disrupting the european healthcare systems with virtual reality and augmented reality applications
$677.6K
End-to-end multidisciplinary optimal design for improved personalized bioactive glass/ceramic bone substitute implants
$229.2K
End-to-end multidisciplinary optimal design for improved personalized bioactive glass/ceramic bone substitute implants
$15,672

Competitors

Name
Shapespark sp. z o.o.
Medi.Com sp. z o.o.
Holo Vectors sp. z o.o.
IQ Med sp. z o.o.
Pergamonmed sp. z o.o.
RSQ Technologies sp. z o.o.
Radpal sp. z o.o.
RSQ Holo sp. z o.o.
Apps4med sp. z o.o.
Idocly sp. z o.o.

Change history

DateEvent
2024-04-18Address change
2022-06-24Share capital increase
2021-07-28Address change
2021-07-08Share capital increase
2020-12-01Share capital increase

FAQ

Last updated: 2026-10-22